Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates & calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Rising demand for poultry products
3.2.1.2 Increased outbreaks of poultry diseases
3.2.1.3 Technological advancements in vaccine development
3.2.2 Industry pitfalls & challenges
3.2.2.1 High cost associated with vaccine development and production
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Porter's analysis
3.6 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company matrix analysis
4.3 Competitive analysis of major market players
4.4 Competitive positioning matrix
4.5 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Product, 2021 – 2032 ($ Mn)
5.1 Key trends
5.2 Attenuated live vaccines
5.3 Inactivated vaccines
5.4 Recombinant vaccines
5.5 Other vaccine types
Chapter 6 Market Estimates and Forecast, By Disease Type, 2021 – 2032 ($ Mn)
6.1 Key trends
6.2 Newcastle disease
6.3 Infectious bronchitis
6.4 Infectious bursal diseases
6.5 Salmonella
6.6 Marek's disease
6.7 Egg drop syndrome
6.8 Adenovirus
6.9 Coccidiosis
6.10 Avian influenza
6.11 Infectious laryngotracheitis
6.12 Avian encephalomyelitis
6.13 Other disease types
Chapter 7 Market Estimates and Forecast, By Application, 2021 – 2032 ($ Mn)
7.1 Key trends
7.2 Breeder
7.3 Layer
7.4 Broiler
Chapter 8 Market Estimates and Forecast, By Dosage Form, 2021 – 2032 ($ Mn)
8.1 Key trends
8.2 Liquid vaccine
8.3 Freeze dried vaccine
Chapter 9 Market Estimates and Forecast, By End-user, 2021 – 2032 ($ Mn)
9.1 Key trends
9.2 Veterinary hospitals & clinics
9.3 Poultry farms
Chapter 10 Market Estimates and Forecast, By Region, 2021 – 2032 ($ Mn)
10.1 Key trends
10.2 North America
10.2.1 U.S.
10.2.2 Canada
10.3 Europe
10.3.1 Germany
10.3.2 UK
10.3.3 France
10.3.4 Spain
10.3.5 Italy
10.3.6 Netherlands
10.3.7 Rest of Europe
10.4 Asia Pacific
10.4.1 China
10.4.2 Japan
10.4.3 India
10.4.4 Australia
10.4.5 South Korea
10.4.6 Rest of Asia Pacific
10.5 Latin America
10.5.1 Brazil
10.5.2 Mexico
10.5.3 Rest of Latin America
10.6 Middle East and Africa
10.6.1 South Africa
10.6.2 Saudi Arabia
10.6.3 UAE
10.6.4 Rest of Middle East and Africa
Chapter 11 Company Profiles
11.1 Biovac
11.2 Boehringer Ingelheim International GmbH
11.3 Ceva Sante Animale
11.4 Dechra Pharmaceuticals PLC
11.5 Elanco Animal Health Incorporated
11.6 Hester Biosciences Limited
11.7 HIPRA
11.8 Merck & Co., Inc.
11.9 Phibro Animal Health Corporation
11.10 Vaxxinova International BV
11.11 Venky's Limited
11.12 Zoetis, Inc.
